(1R,3aR,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol

Catalog No. :
ACMCBD617
CAS No. :
61448-03-1
Molecular Formula :
C30H50O2
Molecular Weight :
442.73

IUPAC Name:(1R,3aR,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol

(1R,3aR,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R,3aR,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol
IUPAC Name(1R,3aR,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol
MDL No.MFCD22417269
Molecular FormulaC30H50O2
Molecular Weight442.73
SMILESC=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
InChI KeyOESLKRXCBRUCJZ-BUXXFNAFSA-N
SynonymLup-20(29)-ene-2alpha,3beta-diol;2alpha-Hydroxylupeol;Lup-20(29)-ene-2,3-diol, (2α,3β)-;Lup-20(29)-ene-2α,3β-diol;2α-Hydroxylupeol;Lup-20(29)-Ene-2alpha,3β-Diol;Lup-20(29)-ene-2α,3beta-diol
CAS No.61448-03-1

Synthetic Route by SureRoute

1. ACMCBD617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMCBD617 route product structure diagram
    ACMCBD61761448-03-1
Inquiry

2. ACMCBD617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMCBD617 route product structure diagram
    ACMCBD61761448-03-1
Inquiry

Comments (0)